{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T04:19:42Z","timestamp":1745986782001,"version":"3.40.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,29]]},"DOI":"10.7759\/cureus.83192","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T16:50:18Z","timestamp":1745945418000},"source":"Crossref","is-referenced-by-count":0,"title":["Renal Leukocyte Chemotactic Factor 2 (ALECT2) Amyloidosis With Concurrent IgA Nephropathy: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Qian","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongzheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said SM","year":"2013","unstructured":"Said SM, Sethi S, Valeri AM, et al.. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol. 2013, 8:1515-23. 10.2215\/CJN.10491012","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-017-0426-6","article-title":"Pathology and diagnosis of renal non-AL amyloidosis","volume":"31","author":"Sethi S","year":"2018","unstructured":"Sethi S, Theis JD. Pathology and diagnosis of renal non-AL amyloidosis. J Nephrol. 2018, 31:343-50. 10.1007\/s40620-017-0426-6","journal-title":"J Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.558","article-title":"Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis","volume":"86","author":"Said SM","year":"2014","unstructured":"Said SM, Sethi S, Valeri AM, et al.. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney Int. 2014, 86:370-7. 10.1038\/ki.2013.558","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2014.02.020","article-title":"Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining","volume":"45","author":"Paueksakon P","year":"2014","unstructured":"Paueksakon P, Fogo AB, Sethi S. Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining. Hum Pathol. 2014, 45:1445-50. 10.1016\/j.humpath.2014.02.020","journal-title":"Hum Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar AD","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016, 387:2641-54. 10.1016\/S0140-6736(15)01274-X","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2024.2405948","article-title":"Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"31","author":"Buxbaum JN","year":"2024","unstructured":"Buxbaum JN, Eisenberg DS, F\u00e4ndrich M, et al.. Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. Amyloid. 2024, 31:249-56. 10.1080\/13506129.2024.2405948","journal-title":"Amyloid"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.08.013","article-title":"Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series","volume":"56","author":"Murphy CL","year":"2010","unstructured":"Murphy CL, Wang S, Kestler D, Larsen C, Benson D, Weiss DT, Solomon A. Leukocyte chemotactic factor 2 (LECT2)-associated renal amyloidosis: a case series. Am J Kidney Dis. 2010, 56:1100-7. 10.1053\/j.ajkd.2010.08.013","journal-title":"Am J Kidney Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1998.tb03855.x","article-title":"Systemic expression of a newly recognized protein, LECT2, in the human body","volume":"48","author":"Nagai H","year":"1998","unstructured":"Nagai H, Hamada T, Uchida T, Yamagoe S, Suzuki K. Systemic expression of a newly recognized protein, LECT2, in the human body. Pathol Int. 1998, 48:882-6. 10.1111\/j.1440-1827.1998.tb03855.x","journal-title":"Pathol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.11","article-title":"Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis","volume":"86","author":"Larsen CP","year":"2014","unstructured":"Larsen CP, Kossmann RJ, Beggs ML, Solomon A, Walker PD. Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis. Kidney Int. 2014, 86:378-82. 10.1038\/ki.2014.11","journal-title":"Kidney Int"},{"key":"ref10","article-title":"Renal leukocyte chemokine type 2 amyloidosis: a clinicopathological analysis of fifteen cases (Article in Chinese)","volume":"53","author":"Wang XY","year":"2024","unstructured":"Wang XY, Han WX, Chen SY, Niu D, Wang XY, Wang C. Renal leukocyte chemokine type 2 amyloidosis: a clinicopathological analysis of fifteen cases (Article in Chinese). Zhonghua Bing Li Xue Za Zhi. 2024, 53:809-15.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12551214","article-title":"Leukocyte cell-derived chemotaxin 2-associated amyloidosis: a recently recognized disease with distinct clinicopathologic characteristics","volume":"10","author":"Nasr SH","year":"2015","unstructured":"Nasr SH, Dogan A, Larsen CP. Leukocyte cell-derived chemotaxin 2-associated amyloidosis: a recently recognized disease with distinct clinicopathologic characteristics. Clin J Am Soc Nephrol. 2015, 10:2084-93. 10.2215\/CJN.12551214","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.29","article-title":"Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians","volume":"29","author":"Larsen CP","year":"2016","unstructured":"Larsen CP, Ismail W, Kurtin PJ, Vrana JA, Dasari S, Nasr SH. Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians. Mod Pathol. 2016, 29:416-20. 10.1038\/modpathol.2016.29","journal-title":"Mod Pathol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2020.1722097","article-title":"Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients","volume":"27","author":"Li DY","year":"2020","unstructured":"Li DY, Liu D, Wang SX, Yu XJ, Cui Z, Zhou FD, Zhao MH. Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients. Amyloid. 2020, 27:134-41. 10.1080\/13506129.2020.1722097","journal-title":"Amyloid"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029638","article-title":"Renal amyloidogenic leukocyte chemotactic factor 2 combined with IgA nephropathy: A case report","volume":"101","author":"Xu H","year":"2022","unstructured":"Xu H, Jia Y, Wang X, Wang H, Yu J, Hao W. Renal amyloidogenic leukocyte chemotactic factor 2 combined with IgA nephropathy: A case report. Medicine (Baltimore). 2022, 101:e29638. 10.1097\/MD.0000000000029638","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw375","article-title":"Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis","volume":"33","author":"Rezk T","year":"2018","unstructured":"Rezk T, Gilbertson JA, Rowczenio D, et al.. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis. Nephrol Dial Transplant. 2018, 33:241-7. 10.1093\/ndt\/gfw375","journal-title":"Nephrol Dial Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359532-renal-leukocyte-chemotactic-factor-2-alect2-amyloidosis-with-concurrent-iga-nephropathy-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T16:50:18Z","timestamp":1745945418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359532-renal-leukocyte-chemotactic-factor-2-alect2-amyloidosis-with-concurrent-iga-nephropathy-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.83192","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}